BI 907828, Ezabenlimab, BI 907828, BI 907828
IB 2023-02
Phase 2 small_molecule active
Quick answer
BI 907828, Ezabenlimab, BI 907828, BI 907828 for Adult patients with locally advanced/metastatic solid tumors is a Phase 2 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Institut für biomedizinische Analytik NMR-Imaging GmbH
- Indication
- Adult patients with locally advanced/metastatic solid tumors
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active